Literature DB >> 20353466

Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy.

R Kido1, Y Shibagaki, K Iwadoh, I Nakajima, S Fuchinoue, T Fujita, S Teraoka.   

Abstract

Although glomerular hematuria is likely a sign of chronic kidney disease that will develop into overt nephropathy after donation, it remains unclear whether prospective donors with hematuria should be excluded. We reviewed the medical records of 242 donors who donated at our institution from 2001 to 2007 and surveyed the prevalence of hematuria pre- and postdonation. We then investigated the association of hematuria with proteinuria postdonation and trends in glomerular filtration rate. Before donation, 8.3% of 242 donors presented with persistent hematuria, a finding that was significantly associated with dysmorphic hematuria before donation. Most cases of predonation persistent hematuria persisted after donation, and the overall prevalence increased to 15.3%. During a median follow-up period of 2.3 years after donation, 8.3% developed persistent proteinuria, with incidence being significantly higher in donors having persistent hematuria with dysmorphic red blood cells (d-RBC) both before and after donation. Postdonation persistent hematuria with d-RBC was also associated with a progressive decline in renal function. These results indicate that persistent glomerular hematuria is strongly associated with a higher incidence of postdonation progressive kidney disease. Potential donors with persistent glomerular hematuria should be excluded, while those with isolated hematuria need to be evaluated with heightened caution.

Entities:  

Mesh:

Year:  2010        PMID: 20353466     DOI: 10.1111/j.1600-6143.2010.03077.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  11 in total

1.  Persistent Microscopic Hematuria as a Risk Factor for Progression of IgA Nephropathy: New Floodlight on a Nearly Forgotten Biomarker.

Authors:  Rosanna Coppo; Fernando C Fervenza
Journal:  J Am Soc Nephrol       Date:  2017-07-24       Impact factor: 10.121

Review 2.  Renal and cardiac assessment of living kidney donor candidates.

Authors:  Ngan N Lam; Krista L Lentine; Amit X Garg
Journal:  Nat Rev Nephrol       Date:  2017-04-03       Impact factor: 28.314

Review 3.  Pathogenesis of glomerular haematuria.

Authors:  Claudia Yuste; Eduardo Gutierrez; Angel Manuel Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Alberto Ortiz; Jesus Egido; Manuel Praga; Juan Antonio Moreno
Journal:  World J Nephrol       Date:  2015-05-06

4.  KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors.

Authors:  Krista L Lentine; Bertram L Kasiske; Andrew S Levey; Patricia L Adams; Josefina Alberú; Mohamed A Bakr; Lorenzo Gallon; Catherine A Garvey; Sandeep Guleria; Philip Kam-Tao Li; Dorry L Segev; Sandra J Taler; Kazunari Tanabe; Linda Wright; Martin G Zeier; Michael Cheung; Amit X Garg
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

Review 5.  Haematuria as a risk factor for chronic kidney disease progression in glomerular diseases: A review.

Authors:  Juan Antonio Moreno; Claudia Yuste; Eduardo Gutiérrez; Ángel M Sevillano; Alfonso Rubio-Navarro; Juan Manuel Amaro-Villalobos; Manuel Praga; Jesús Egido
Journal:  Pediatr Nephrol       Date:  2015-05-17       Impact factor: 3.714

6.  Guidelines for Genetic Testing and Management of Alport Syndrome.

Authors:  Judy Savige; Beata S Lipska-Zietkiewicz; Elizabeth Watson; Jens Michael Hertz; Constantinos Deltas; Francesca Mari; Pascale Hilbert; Pavlina Plevova; Peter Byers; Agne Cerkauskaite; Martin Gregory; Rimante Cerkauskiene; Danica Galesic Ljubanovic; Francesca Becherucci; Carmela Errichiello; Laura Massella; Valeria Aiello; Rachel Lennon; Louise Hopkinson; Ania Koziell; Adrian Lungu; Hansjorg Martin Rothe; Julia Hoefele; Miriam Zacchia; Tamara Nikuseva Martic; Asheeta Gupta; Albertien van Eerde; Susie Gear; Samuela Landini; Viviana Palazzo; Laith Al-Rabadi; Kathleen Claes; Anniek Corveleyn; Evelien Van Hoof; Micheel van Geel; Maggie Williams; Emma Ashton; Hendica Belge; Elisabet Ars; Agnieszka Bierzynska; Concetta Gangemi; Alessandra Renieri; Helen Storey; Frances Flinter
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-20       Impact factor: 8.237

7.  Latent abnormal pathology affects long-term graft function in elder living renal allograft recipients.

Authors:  Linlin Ma; Lei Zhang; Yu Du; Zelin Xie; Yawang Tang; Jun Lin; Wen Sun; Hongbo Guo; Rumei Bi; Mengmeng Zhang; Xi Zhu; Ye Tian
Journal:  Clin Dev Immunol       Date:  2013-09-19

8.  Haematuria increases progression of advanced proteinuric kidney disease.

Authors:  Claudia Yuste; Alfonso Rubio-Navarro; Daniel Barraca; Inés Aragoncillo; Almudena Vega; Soraya Abad; Alba Santos; Nicolás Macias; Ignacio Mahillo; Eduardo Gutiérrez; Manuel Praga; Jesús Egido; Juan Manuel López-Gómez; Juan Antonio Moreno
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 9.  Controversies related to living kidney donors.

Authors:  Ahmed I Kamal; Ahmed M Harraz; Ahmed A Shokeir
Journal:  Arab J Urol       Date:  2011-12-09

10.  Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.

Authors:  Sadanori Okada; Ken-Ichi Samejima; Masaru Matsui; Katsuhiko Morimoto; Riri Furuyama; Kaori Tanabe; Masahiro Eriguchi; Yasuhiro Akai; Yoshihiko Saito; Kazuhiko Tsuruya
Journal:  BMJ Open Diabetes Res Care       Date:  2020-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.